---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000071"
form_type: "8-K/A"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:51:52.929787+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Clover Health publishes supplemental shareholder Q&A; no new financial data disclosed

## Summary
- Filed 8-K/A on March 6, 2026 furnishing a supplemental Q&A document related to Q4 2025 earnings.
- Document contains selected responses to shareholder questions but includes no specific financial or operational metrics.
- CEO Andrew Toy reaffirms commitment to shareholder transparency in the accompanying letter.
- Q&A is also available on the investor relations page of Clover Health's website.

## SEC filing metadata
- accession: 0001801170-26-000071
- form_type: 8-K/A
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/0001801170-26-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/clov-20260306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000071
- JSON: https://secwatch.observer/filing/0001801170-26-000071.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.